Clinical Trial Update: A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 repeated-dose study of sarilumab in children and adolescents with systemic juvenile idiopathic arthritis. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Juvenile Idiopathic Arthritis | Phase 2 | Status: RECRUITING